1. Gesetz zur Änderung betäubungsmittelrechtlicher und anderer Vorschriften [Act to Amend Narcotic Drugs Provisions and Other Related Provisions] (Amendment Act), March 6, 2017, Bundesgesetzblatt [BGBl.] [FEDERAL LAW GAZETTE] I at 403.
  2. Freeman AM, Petrilli K, Lees R, et al. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neurosci Biobehav Rev. 2019;107: 696–712.
  3. Schmidt-Wolf G, Cremer-Schaeffer P. 3 Jahre Cannabis als Medizin – Zwischenergebnisse der Cannabisbegleiterhebung. Bundesgesundheitsblatt. 2021;64: 368-377.
  4. O’Brien C. Reimbursed sales of medical cannabis in Germany grew by 34% in 2020. News release. Prohibition Partners. April 16, 2021. Accessed November 10, 2021: https://prohibitionpartners.com/2021/04/16/reimbursed-sales-of-medical-cannabis-in-germany-grew-by-34-in-2020/